AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2013
Feb 21, 2013
29755_dirs_2013-02-21_89c973da-b5b3-4828-a4ed-c8c95c233160.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-02-19
Reporting Person: LEONARD JOHN M. (SVP, Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-19 | Common stock, $0.01 par value | M | 29650 | $27.294 | Acquired | 174326 | Direct |
| 2013-02-19 | Common stock, $0.01 par value | F | 25345 | $37.58 | Disposed | 148981 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-19 | Option (right to buy) | $27.2940 | M | 29650 | Disposed | 2017-02-15 | Common stock (29650) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common stock, $0.01 par value | 6473 | Indirect |
Footnotes
F1: Balance in the AbbVie Savings Program as of February 19, 2013.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4